Ivacaftor treatment was demonstrated to improve exocrine pancreatic function as well as insulin secretion profile, which may alleviate or even reverse CF-related diabetes (Hayes et al., 2014; Davies et al., 2016; Tsabari et al., 2016; Kelly et al., 2019). The gene discussed is INS; the disease is cystic fibrosis.